- $185.04m
- -$14.80m
- $13.00m
U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, Walmart
Evommune soars after eczema therapy shows promise in mid-stage trial
Evommune soars after eczema therapy shows promise in mid-stage trial
Aktis Oncology files for US IPO as biotech listings rebound
Live Markets: S&P 500 wraps up biggest profit growth season since Q4 2024
Live Markets: Stephens tweaks view for 2026 Russell Recon
Evommune surges in NYSE debut after $150 million IPO